ACP · Jun 23, 2026
ACP, Annals forum addressed care of patients on GLP-1 receptor agonists
ACP and Annals of Internal Medicine presented a virtual live forum on care of patients on glucagon-like peptide-1 (GLP-1) receptor agonists on June 17.
Guidelines & Practice · page 7
Practice updates and recommendations from the major professional societies.
FDA Drugs · Jun 23, 2026
Guidance Snapshot Pilot
Guidance Snapshots are a communication tool that provide highlights from the document using visuals and plain language. This pilot program is intended to increase awareness for FDA guidance documents to support the efficient application of the documents’ recommendations.
ACC (Cardiology) · Jun 23, 2026
Genotype Independently Predicts HF Outcomes in Patients With HCM
In patients with hypertrophic cardiomyopathy (HCM), genotype, peak VO2, log NT-proBNP and LVEF independently predict heart failure (HF) outcomes, and combining these measures identified patients at higher risk of HF-related death or transplant, according to a recent study published in JACC: Heart Failure.
ACC (Cardiology) · Jun 23, 2026
ACCEL Lite: Prehospital Heparin Administration In Patients With STEMI Undergoing Primary PCI
In this interview, Kim Allan Williams Sr., MD, MACC and Misa Fister, MD, PhD examine ‘Prehospital Heparin Administration In Patients With STEMI Undergoing Primary PCI’.
ADA (Diabetes) · Jun 22, 2026
New Survey: Nearly 40 Percent of Insulin Users Polled Pay More Than $150 Per Month
New Survey: Nearly 40 Percent of Insulin Users Polled Pay More Than $150 Per Month mcarmody Mon, 06/22/2026 - 15:51 Press release New Survey: Nearly 40 Percent of Insulin Users Polled Pay More Than $150 Per Month ARLINGTON, Va. June 23, 2026 New polling released today by the American Diabetes Association ® (ADA) finds that among respondents who rely on insulin, 72% report paying more than $35 per month, and nearly 40% pay more than $150 monthly. Cost is a more pronounced problem among middle-class Americans with diabetes—44% of insulin-dependent individuals who make between $50,000 and $75,000…
FDA Drugs · Jun 22, 2026
Phase 1 IND Guidance Documents
Find FDA Guidance Documents related to Phase 1 IND submissions
FDA Drugs · Jun 22, 2026
Guidance Recap Podcast | Master Protocols for Drug and Biological Product Development
Guidance Recap Podcast | Master Protocols for Drug and Biological Product Development
ACP · Jun 19, 2026
Dr. Lacy C. Hobgood receives the 2026 Richard Neubauer Advocate for Internal Medicine Award
Hobgood has successfully advocated for passage of comprehensive heart-safety and emergency preparedness legislation in his state.
ACC (Cardiology) · Jun 19, 2026
JACC Progress Report: Excess CV Mortality Persists in Black Americans
While there may have been a modest improvement in excess cardiovascular mortality in Black Americans compared with White Americans from 2023 to 2024 and a trend toward partial recovery from the pandemic era, there remains a persistent racial disparity...
ACC (Cardiology) · Jun 18, 2026
AI-Enabled Clinician: Building Clinical Autonomy with Large Language Models
In this episode, Chief Innovation Officer Dr. Ami Bhatt and Dr. Katie Berlacher discuss how large language models (LLMs) can be integrated into clinical workflows and medical education while preserving clinical autonomy.
ACC (Cardiology) · Jun 18, 2026
ACC CardiaCast: Treating PSVT
This episode is part of ACC's ongoing educational initiative to enhance the recognition, diagnosis, and management of paroxysmal supraventricular tachycardia (PSVT).
ACC (Cardiology) · Jun 18, 2026
21-Year DPP Follow-Up: Lifestyle Intervention, But Not Metformin, Lowers Multimorbidity Risk in Prediabetes
An intensive lifestyle intervention was associated with a lower long-term burden of multimorbidity among adults with prediabetes, while metformin was not associated with a statistically significant reduction vs. placebo, according to a 21-year follow-up analysis of the Diabetes Prevention Program...
ACC (Cardiology) · Jun 17, 2026
2025 Journal Impact Factor Scores Announced
When information is everywhere, credibility is everything. The newly released Clarivate Journal Impact Factors reflect the broad global reach and influence of JACC and the entire JACC Journals family.
ACC (Cardiology) · Jun 17, 2026
CV Risk Factor Treatment, Control Rates Low Among Adults With CKM
Treatment of hypertension and hyperlipidemia was low among U.S. adults with cardiovascular-kidney-metabolic (CKM) syndrome, with less than half achieving blood pressure or glycemic control, and gaps in starting treatment were greatest among women, young adults and Hispanic adults. Furthermore, inadequate risk factor control was highest among those with the highest cardiovascular risk, according to research published June 17 in JACC.
ADA (Diabetes) · Jun 17, 2026
Meet Ismael: Using His Voice for Change and a Better Future
Meet Ismael: Using His Voice for Change and a Better Future mseibold Wed, 06/17/2026 - 15:51 Type 1 Advocacy Share Your Story By sharing your story, you help us raise awareness of diabetes so we can bend the curve on it once and for all. Will you help us awaken the world? Share Your Story
ACC (Cardiology) · Jun 17, 2026
Eagle’s Eye View: Race and Sex Disparities in Mitral Valve Edge-to-Edge Repair
In this week’s View, Dr. Eagle highlights a study showing race and sex disparities in M-TEER outcomes, with Black patients presenting with more advanced disease, lower success, and higher heart failure readmissions than White patients, and women having lower success rates than men.
ACC (Cardiology) · Jun 16, 2026
CAMERA-MRI II: Catheter Ablation in Patients With AFib and LVSD by LGE Status
In patients with atrial fibrillation (AFib) and left ventricular systolic dysfunction (LVSD), catheter ablation was associated with substantial improvement in LVEF regardless of late gadolinium enhancement (LGE) status, while 12-month LVEF and normalization rates were lower in patients with LGE present, according to results from the CAMERA-MRI II trial published June 8 in JACC: Clinical Electrophysiology.
ACC (Cardiology) · Jun 16, 2026
Implications of the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline for Lipid Management in Vascular Disease
Lipid management remains a cornerstone of secondary prevention in atherosclerotic cardiovascular disease (ASCVD), with increasingly strong evidence supporting its central role across all vascular territories, including coronary, cerebrovascular, and peripheral arterial beds.
ACC (Cardiology) · Jun 16, 2026
ACCEL Lite: Definitions and Treatment of Iron Deficiency in HF: Feel and Function or More?
In this interview, Clyde W. Yancy MD, MACC and Robert J. Mentz, MD, FACC examine definitions and treatment of ID in HF.
ACC (Cardiology) · Jun 16, 2026
VitaK-CAC: Menaquinone-7 Attenuates CAC in CAD
Supplementation with the vitamin K homologue menaquinone-7 (MK-7) significantly attenuated coronary artery calcification (CAC) compared with placebo in adults with symptomatic coronary artery disease (CAD), according to research published June 10 in JAMA Cardiology.
ACC (Cardiology) · Jun 16, 2026
BIHCA: Sodium Bicarbonate Holds No Benefit For In-Hospital Cardiac Arrest
Administration of sodium bicarbonate made no significant difference in the sustained return of spontaneous circulation, compared with placebo, in patients who suffered an in-hospital cardiac arrest, according to research published June 11 in JAMA.
ACC (Cardiology) · Jun 16, 2026
LOGICAL: Conservative Oxygen Therapy Fails to Improve Survival Outcomes After Cardiac Arrest
When compared with liberal oxygen therapy, conservative oxygen therapy did not improve rates of survival with favorable functional outcomes among unresponsive patients in the intensive care unit (ICU) receiving mechanical ventilation after cardiac arrest, according to results from the investigator-initiated, open-label LOGICAL trial published June 10 in NEJM.
ADA (Diabetes) · Jun 16, 2026
The American Diabetes Association Applauds Louisiana Lawmakers for Advancing Diabetes-Related Amputation Prevention through House Resolution 267
The American Diabetes Association Applauds Louisiana Lawmakers for Advancing Diabetes-Related Amputation Prevention through House Resolution 267 vcramer Tue, 06/16/2026 - 12:54 Advocacy News The American Diabetes Association Applauds Louisiana Lawmakers for Advancing Diabetes-Related Amputation Prevention through House Resolution 267 Baton Rogue, LA June 16, 2026 The American Diabetes Association® (ADA) applauds the Louisiana House of Representatives for passing House Resolution 267 (HR 267), a measure establishing a comprehensive study focused on the prevention and reduction…
ACP · Jun 15, 2026
ACP issues new living clinical guideline on using medications to manage overweight and obesity
PHILADELPHIA, June 15, 2026 – The American College of Physicians (ACP) has issued a new living clinical guideline to help physicians choose medications with lifestyle modifications to manage overweight and obesity in adults. “ Pharmacologic Treatments with Lifestyle Modifications in Nonpregnant Adults with Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline from the American College of Physicians” is published in Annals of Internal Medicine . More than half (59%) of the world’s population has overweight or obesity, chronic conditions…